Poolbeg Pharma PLC (AIM:POLB)
London
· Delayed Price · Currency is GBP · Price in GBX 3.611
-0.039 (-1.07%)
Dec 5, 2025, 4:21 PM GMT+1
Poolbeg Pharma Market Cap
Poolbeg Pharma has a market cap or net worth of 25.45 million as of December 5, 2025. Its market cap has decreased by -33.47% in one year.
Market Cap
25.45M
Enterprise Value
15.49M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.61
Market Cap Chart
Since July 19, 2021, Poolbeg Pharma's market cap has decreased from 53.75M to 25.45M, a decrease of -52.66%. That is a compound annual growth rate of -15.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 25.45M | -28.32% |
| Dec 31, 2024 | 35.50M | -21.55% |
| Dec 29, 2023 | 45.25M | 49.59% |
| Dec 30, 2022 | 30.25M | -36.32% |
| Dec 31, 2021 | 47.50M | -11.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.35B |
| GSK plc | 73.29B |
| Haleon | 32.16B |
| Smith & Nephew | 10.44B |
| Convatec Group | 4.46B |
| Hikma Pharmaceuticals | 3.52B |
| HUTCHMED (China) | 1.85B |
| Genus | 1.77B |